BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12714853)

  • 1. Trough-to-peak ratio, smoothness index and morning-to-evening ratio: why, which and when?
    Zannad F; Radauceanu A; Parati G
    J Hypertens; 2003 May; 21(5):851-4. PubMed ID: 12714853
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the smoothness index, the trough : peak ratio and the morning : evening ratio in assessing the features of the antihypertensive drug effect.
    Stergiou GS; Efstathiou SP; Skeva II; Baibas NM; Roussias LG; Mountokalakis TD
    J Hypertens; 2003 May; 21(5):913-20. PubMed ID: 12714865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trough-to-peak ratio as an instrument to evaluate antihypertensive drugs. The APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension Trial.
    Staessen JA; Bieniaszewski L; Buntinx F; Celis H; O'Brien ET; van Hoof R; Fagard R
    Hypertension; 1995 Dec; 26(6 Pt 1):942-9. PubMed ID: 7490153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension.
    Parati G; Omboni S; Rizzoni D; Agabiti-Rosei E; Mancia G
    J Hypertens; 1998 Nov; 16(11):1685-91. PubMed ID: 9856370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension.
    Eguchi K; Kario K; Shimada K
    Am J Cardiol; 2003 Sep; 92(5):621-4. PubMed ID: 12943892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements.
    Stergiou GS; Efstathiou SP; Skeva II; Baibas NM; Kalkana CB; Mountokalakis TD
    J Hum Hypertens; 2002 Oct; 16(10):729-35. PubMed ID: 12420198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan.
    Szauder I; Csajági E; Major Z; Pavlik G; Ujhelyi G
    Kidney Blood Press Res; 2015; 40(4):374-85. PubMed ID: 26160625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renin-angiotensin-aldosterone inhibitors for treatment of hypertension with abnormal circadian rhythm of blood pressure].
    Yagi S; Sata M
    Nihon Rinsho; 2014 Aug; 72(8):1466-71. PubMed ID: 25167754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent nurse visits decrease white coat effect in stage III hypertension.
    Guerra-Riccio GM; Artigas Giorgi DM; Consolin-Colombo FM; Barreto-Filho JA; Lopes HF; Fleury Camargo AL; Moacyr Krieger E
    Am J Hypertens; 2004 Jun; 17(6):523-8. PubMed ID: 15177526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
    Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
    Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering effect and duration of action of bedtime administration of doxazosin determined by home blood pressure measurement.
    Gonokami K; Obara T; Kobayashi M; Katada S; Hara A; Metoki H; Asayama K; Kikuya M; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2010; 32(5):311-7. PubMed ID: 20662733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in very old people.
    Kjeldsen SE; Os I
    J Hypertens; 2003 Dec; 21(12):2249-50. PubMed ID: 14654743
    [No Abstract]   [Full Text] [Related]  

  • 20. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.